Changhua Zhang Selected Research

Thioredoxin Reductase 1

1/2021

Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changhua Zhang Research Topics

Disease

61	Neoplasms (Cancer) 04/2024 - 01/2012
47	Stomach Neoplasms (Stomach Cancer) 01/2024 - 02/2012
15	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2016
10	Adenocarcinoma 01/2022 - 01/2012
8	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 08/2016
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2012
5	Carcinogenesis 01/2024 - 11/2016
3	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 12/2020
2	Microsatellite Instability 02/2024 - 01/2023
2	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2020
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 12/2018
1	Alopecia (Baldness) 01/2024
1	Skin Neoplasms (Skin Cancer) 12/2023
1	Tertiary Lymphoid Structures 01/2023
1	Liposarcoma 01/2023
1	Bites and Stings (Sting) 01/2023
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Juvenile Myelomonocytic Leukemia 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Turcot syndrome 01/2023

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 01/2013
6	Immune Checkpoint InhibitorsIBA 01/2023 - 03/2021
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
6	Long Noncoding RNAIBA 03/2021 - 08/2016
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2016
5	130-nm albumin-bound paclitaxelIBA 12/2021 - 01/2013
4	Carrier Proteins (Binding Protein)IBA 04/2024 - 10/2022
4	Indicators and Reagents (Reagents)IBA 01/2024 - 10/2021
4	N-methyladenosineIBA 10/2022 - 01/2020
4	Proton Pump InhibitorsIBA 12/2021 - 01/2020
4	Gemcitabine FDA Link 10/2013 - 01/2012
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2024 - 10/2022
3	nintedanibIBA 01/2023 - 11/2018
3	Sunitinib (Sutent)FDA Link 01/2023 - 01/2012
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
3	Angiogenesis InhibitorsIBA 01/2022 - 05/2014
3	(1,2- bis(1,2- benzisoselenazolone- 3(2H)- ketone))ethaneIBA 01/2022 - 01/2020
3	Albumin-Bound Paclitaxel FDA Link 05/2014 - 01/2013
2	LipidsIBA 12/2023 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 07/2023 - 03/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2022
2	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 01/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 01/2022
2	Docetaxel (Taxotere)FDA Link 01/2023 - 10/2013
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2021
2	Histones (Histone)IBA 01/2022 - 12/2019
2	CateninsIBA 01/2022 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 10/2021 - 12/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2013
2	Insulin (Novolin)FDA Link 01/2021 - 12/2012
2	Thioredoxin-Disulfide ReductaseIBA 01/2021 - 01/2020
2	WT161IBA 01/2021 - 12/2019
2	CXC ChemokinesIBA 01/2019 - 11/2016
2	Bevacizumab (Avastin)FDA Link 05/2014 - 01/2012
1	Interleukin-18 (Interleukin 18)IBA 01/2024
1	Circular RNAIBA 01/2024
1	Drug CarriersIBA 12/2023
1	PolymersIBA 12/2023
1	Transferrin (beta 2 Transferrin)IBA 07/2023
1	IronIBA 07/2023
1	Lipid PeroxidesIBA 07/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 07/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	atezolizumabIBA 01/2023
1	aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA 01/2023
1	DNA HelicasesIBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	MetalsIBA 01/2023
1	AcetaldehydeIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	Competitive Endogenous RNAIBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	Caspase 1 (ICE Protease)IBA 01/2023
1	DisulfidesIBA 01/2023
1	Hydroxyl RadicalIBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023

Therapy/Procedure

20	Therapeutics 04/2024 - 01/2012
13	Drug Therapy (Chemotherapy) 12/2023 - 11/2018
10	Immunotherapy 02/2024 - 01/2022
4	Radiotherapy 12/2023 - 10/2020
3	Gastrectomy 01/2023 - 01/2014
2	Precision Medicine 04/2024 - 01/2023
2	Adjuvant Chemotherapy 01/2023 - 11/2020
2	Hyperthermic Intraperitoneal Chemotherapy 01/2023 - 01/2022
2	Neoadjuvant Therapy 10/2022 - 11/2020
2	Lymph Node Excision (Lymph Node Dissection) 01/2014 - 01/2014
1	Cytoreduction Surgical Procedures 01/2023